Back to Search

A Phase 1/1b Study of SRF388 in Patients With Advanced Solid Tumors


  • Protocol Number: 202004075
  • Principal Investigator: Morgensztern, Daniel
  • Cancer Types: Early Phase, Lung

For more information on this trial, contact us here:

Phone
800-600-3606
Email
info@ccadmin.wustl.edu

Brief Summary

Protocol Interventions